Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma

NCT00198133 is registered in ClinicalTrials.gov with Patrick Joseph Loehrer Sr. as lead sponsor.

NCT NCT00198133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00198133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Lead sponsor
Patrick Joseph Loehrer Sr.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
May 31, 2012
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thymic carcinoma, thymoma